1Flamm ES,Demopoulos HB,Seligman ML,et al.Free radicals in cerebral ischemia[J].Stroke,1978,9:445-447
2Lces KR, Dawson J. Advances in emerging therapies 2006[J]. Stroke, 2007,38:219-221.
3Sorhera I.A. Free radicals trapping agent NXY - 059 for therapies on acute ischemic slrokes[J], Drugs Future, 2002,27(3):240- 247.
4Strid S, Borga O, Edenius C, et al. Pharmacokinetics in renally impaired subjects of NXY - 059, a nitrone - based, free - radical trapping agent developed for the treatment of acute stroke[J]. Eur J Clin Pharmacol,2002,58(6):409 - 415.
5Sydserff SG, Borelli AR, Green AR, et al. Effect of NXY-059 on infact volume after transienl or permanent middle cerebral in the rat:Studies on dose, plasma concentration and therapeutic time windows[J]. Br J Pharmacol,2002,135:102 - 103.
6Marshall JW, Duffin ICI, Green AR, et al. NXY- 059,free radicals trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate species editorial comment[J]. Stroke,2001,32(1):190-198.
7Han M, He QP, Yong G, et al. NXY-059,a nitrone with free radicals trapping properties inhibits release of cytochrome, C after focal cerebral ischemia [ J ]. Cell Mol Biol ( Noisy - le - grand), 2003,49(8) : 1249 - 1252.
8Yoshimoto T, Kanakaraj P, Ying M J, et al. NXY-059 maintains Akt activation and inhibits release of cytochrome C after focal cere bral ischemia[J]. Brain Res,2002,974(2) :191 - 198.
9Kuroda S, Tsuchidate R, Smith ML, et al. Neuroprotective effects of a novel nitrone, NXY-059,after transient focal cerebral ischemia in rat[J]. J Cereb Blood Flow Metab, 1999,19:778 -787.
10Jonathan WB, Marshall A,Richard G,et al. Comparison of the neuroprotective effect of clomethiazole, AR - R15896AR and NXY- 059 in a primate model of stroke using histological and behavioural measures[J]. Brain Research,2003,972 : 119 - 126.
